Metformin is often associated with lactic acidosis, especially in patients with kidney disease. A recently published study questions this association in patients with mild to moderate disease.
Read More »Metformin: A Potential Anti-Cancer Agent
Use of metformin was associated with a 16% reduced risk for overall mortality in patients with type 2 diabetes and pancreatic cancer.
Read More »Glycemic and Adiposity Benefits with Metformin Use in Pregnancy
A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.
Read More »Improved Post-Surgical Outcomes in Patients Using Metformin
Metformin use was associated with lower inflammatory markers before surgery, leading to improved outcomes post-surgery.
Read More »Risk of Anemia with Metformin Use in Patients with Type 2 Diabetes
Metformin use can reduce protein hemoglobin levels that carry oxygen in the blood.
Read More »T2DM Medications: All-Star Team Lineup
A recently published meta-analysis puts metformin to the test to see how well it lines up against other T2DM “Medication All-Star Team” members.
Read More »Impact of Physical Activity and Metformin on Postprandial Glucose
Lifestyle modifications as first-line treatment have paramount importance on the quality of life.
Read More »Common Diabetes Drug Linked To Lower Dementia Rates
One of the most commonly prescribed medications worldwide may have a hidden benefit.
Read More »How Cost and Formulation Affect Patient Adherence to Metformin Therapy
Improving medication adherence can reduce healthcare expenditures while producing healthier patients.
Read More »Examining the Risks of Antihyperglycemic Dual and Triple Therapies for T2D
A closer look at the risk of major adverse events, severe hypoglycemia, and all-cause mortality for commonly used therapies in treating type 2 diabetes.
Read More »